Giltuss Allergy Plus

Giltuss Allergy Plus is an FDA-registered drug product whose active ingredient is CHLOPHEDIANOL HCL, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL. It is labelled by Gil Pharmaceutical Corp taken by oral and marketed as a human otc drug product. Identifiers on file: NDC 58552-334, application M012, label effective 20260723. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

Across FDA labelling, products containing CHLOPHEDIANOL HCL, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL are most often described in connection with: temporarily relieves, common cold, runny nose, watery eyes, due hay, upper respiratory, nasal congestion, controls cough. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Uses Temporarily relieves runny nose, sneezing, and itchy and watery eyes due to hay fever or other upper respiratory allergies. Temporarily relieves nasal congestion due to the common cold. Temporarily controls cough due to minor bronchial irritation occurring with the common cold.

Directions Adults and Children 12 years and over: Take 1 tablet every 6-8 hours. Do not take more than 4 tablets in a 24-hour period. Children 6 to 12 years of age: Take 1/2 tablet every 6-8 hours. Do not take more than 2 tablets in a 24-hour period. Children under 6 years: Consult a physician.

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have: heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland a breathing problem such as emphysema or chronic bronchitis glaucoma persistent or chronic cough such as occurs with smoking, asthma chronic bronchitis, or emphysema excessive phlegm (mucus) Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product: do not exceed recommended dose excitability may occur, especially in children drowsiness may occur alcohol, sedatives, and tranquilizers may increase drowsiness avoid alcoholic drinks be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if: nervousness, dizziness, or sleeplessness occurs symptoms do not improve within 7 days or occur with a fever cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache If pregnant or breast-feeding , ask a health professional before use Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

What is Giltuss Allergy Plus used for?
Uses Temporarily relieves runny nose, sneezing, and itchy and watery eyes due to hay fever or other upper respiratory allergies. Temporarily relieves nasal congestion due to the common cold. Temporarily controls cough due to minor bronchial irritation occurring with the common cold.

Who makes Giltuss Allergy Plus?
Gil Pharmaceutical Corp is the labeler of record for Giltuss Allergy Plus.

What form does Giltuss Allergy Plus come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is Giltuss Allergy Plus prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Has Giltuss Allergy Plus been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.